Delivery Order N0016411DJN67-0002

<p>The National Institute on Deafness and Other Communication Disorders issued a delivery order to Illumina, Inc. on July 18, 2017, with a ceiling value of $9,196.32.</p> <p>Place of performance is San Diego, CA 92122. Ultimate completion date is September 2, 2020. The order is priced on a firm fixed-price basis with no set-aside designation. The source does not identify the parent vehicle or specific deliverables for this order.</p>

The National Human Genome Research Institute issued a delivery order to ICF Incorporated, L.L.C. on December 18, 2018, with a ceiling value of $48,604.00 for labor, other direct costs, and fees supporting the Sixth International Conference on Rare and Undiagnosed Diseases in Italy. The order is placed under the Professional Services Schedule (PSS). Place of performance is Bethesda, MD 20892. The ultimate completion date is May 29, 2019. The order is priced on a firm fixed-price basis with no...

<p>The National Institute of Neurological Disorders and Stroke issued a $26,597.20 delivery order to Illumina, Inc. on August 19, 2020, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with no set-aside designation and an ultimate completion date of September 2, 2020. The source does not name a parent IDIQ or GWAC vehicle for this delivery order.</p>

This is a firm fixed-price delivery order awarded by the Naval Sea Systems Command (NAVSEA), a defense agency, to HII Mission Driven Innovative Government Solutions Inc. for IVCN and ICAN support services. The contract has a ceiling value of $369,994.73 and an ultimate completion date of February 15, 2016. The contract is not set aside for any specific business type. As this is a delivery order, it is likely part of a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle, but...

<p>The National Eye Institute issued a $62,076.07 delivery order to Illumina, Inc. on February 3, 2016, for genetic sequencing and genomic analysis technologies. The order was closed out on February 12, 2016.</p> <p>Place of performance is Bethesda, MD. The delivery order was issued as firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute issued a delivery order to Illumina, Inc. on February 12, 2018, with a ceiling value of $5,223.14 for genetic sequencing products and services. Place of performance is San Diego, CA 92122. The order was firm fixed price with ultimate completion by September 2, 2020.</p>

<p>The National Cancer Institute issued a $13,043.75 delivery order to Illumina, Inc. on June 20, 2018, for genetic sequencing and genomic analysis technologies. Place of performance is Bethesda, MD. Ultimate completion date is July 19, 2018.</p> <p>The source does not identify the parent vehicle under which this delivery order was issued.</p>

<p>The National Institute of Child Health and Human Development issued a delivery order to Illumina, Inc. on June 29, 2018, with a ceiling value of $15,877.72 for genetic sequencing and genomic analysis technologies. Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of August 29, 2018. No set-aside was used.</p>

<p>The National Institute of Child Health and Human Development issued a delivery order to Illumina, Inc. on May 6, 2019, with a ceiling value of $10,125.54 for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

<p>The National Eye Institute issued a delivery order to Illumina, Inc. on May 3, 2012, with a ceiling value of $120,412.50 for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of August 31, 2015. No set-aside was used.</p>